| Application no. and date | 17828625.8 (espacenet) (Federated) (European Patent Register), 20170717 | | Patent/reg. no. and date | DK/EP 3484524, 20221109 | | Publication date | 20190522 | | Priority no. and date | US 201662363195 P, 20160715 | | EP pub. no. and date |
EP 3484524 20190522 | | Effective date | | | Applicant/owner | Ionis Pharmaceuticals, Inc., 2855 Gazelle Court
Carlsbad, CA 92010, US | | Applicant ref. no. | P80979DK01 | | Inventor | PRAKASH, Thazha, P., 2855 Gazelle Ct.
Carlsbad, CA 92010, US,
SETH, Punit, P., 2855 Gazelle Ct.
Carlsbad, CA 92010, US,
RIGO, Frank, 2855 Gazelle Ct.
Carlsbad, CA 92010, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 48/00 (2006.01) , A61P 21/00 (2006.01) , C07H 21/02 (2006.01) | | Title | FORBINDELSER OG FREMGANGSMÅDER TIL MODULATION AF SMN2 | | Int. application no. | US2017042463 | | Int. publication no. | WO2018014041 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
